The application of high-flow nasal cannula oxygen with different oxygen concentrations in pediatric patients undergoing flexible bronchoscop

Status

Active, not recruiting

Phases

Early Phase 1

Study type

Interventional

Source

ChiCTR

Registry ID

ChiCTR2400087847

Enrollment

Unknown

Registered

2024-08-06

Start date

2024-08-12

Completion date

Unknown

Last updated

2024-08-12

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Hyoxemia

Interventions

40% Group:40% oxygen concentration with high-flow nasal cannula oxygen

70% Group:70% oxygen concentration with high-flow nasal cannula oxygen

100% Group:100% oxygen concentration with high-flow nasal cannula oxygen

Eligibility

Sex/Gender

All

Age

5 Years to 12 Years

Inclusion criteria

Inclusion criteria: ?Age 5-12 years;?American Society of Anesthesiologists physical status I-II; ?Fiberoptic bronchoscopy under general anesthesia

Exclusion criteria

Exclusion criteria: ?Indications of tracheal intubation;?Cannot tolerate fiberoptic bronchoscopy or HFNC;?Preoperative SpO230kg/m2;?High risk of aspiration;?Nasal bleeding or abnormal nasal anatomy;?Decreased consciousness; ?The duration of bronchoscopy is less than 10 minutes;?Deny participant;?Other serious cardiovascular and respiratory diseases

Design outcomes

Primary

Measure	Time frame
Lowest SpO2;Incidence of SpO2 <90%;	—

Secondary

Measure	Time frame
Percutaneous partial pressure of carbon dioxide;Percutaneous oxygen pressure;Cerebral and tissue oxygen saturation;	—

Countries

China

Contacts

Public ContactXiangsheng Xiong

Huai'an Hospital Affiliated to Yangzhou University (The Fifth People's Hospital of Huai'an)

158193942@qq.com+86 177 9898 2001

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026